TTNP

Titan Pharmaceuticals
TTNP

Overview Fund Trends Analyst Outlook
Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

26 hedge funds and large institutions have $909K invested in Titan Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
4
Closed
5
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$4K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$391K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$54.4K
3
VF
Virtu Financial
New York
+$45K
4
Citadel Advisors
Citadel Advisors
Florida
+$18K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$17K

Top Sellers

1
CWM
Cornerstone Wealth Management
Missouri
-$1M
2
SM
Sabby Management
Florida
-$314K
3
PCM
Perkins Capital Management
Minnesota
-$147K
4
Renaissance Technologies
Renaissance Technologies
New York
-$99.9K
5
AC
Armistice Capital
New York
-$46K
Name Holding Trade Value Shares
Change 		Shares
Change %
AC
26
Armistice Capital
New York
– -$46K -61 Closed
BA
27
Ballew Advisors
Mississippi
– -$1K -1 Closed
CWM
28
Cornerstone Wealth Management
Missouri
– -$1M -1 Closed
HNB
29
Huntington National Bank
Ohio
– -$1K – –
1
2